| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.86B | 41.69B | 41.53B | 43.45B | 46.30B | 51.76B |
| Gross Profit | 9.42B | 9.37B | 9.38B | 9.60B | 9.91B | 11.64B |
| EBITDA | 2.20B | 2.28B | 2.21B | 2.60B | 2.74B | 3.92B |
| Net Income | 1.14B | 1.07B | 927.00M | 1.24B | 1.42B | 2.45B |
Balance Sheet | ||||||
| Total Assets | 14.89B | 14.67B | 14.78B | 14.97B | 15.80B | 17.50B |
| Cash, Cash Equivalents and Short-Term Investments | 1.75B | 1.74B | 1.58B | 1.45B | 1.87B | 2.94B |
| Total Debt | 4.13B | 4.13B | 4.05B | 3.98B | 3.98B | 3.94B |
| Total Liabilities | 11.81B | 11.71B | 11.97B | 11.91B | 13.01B | 14.48B |
| Stockholders Equity | 3.08B | 2.96B | 2.81B | 3.05B | 2.79B | 3.02B |
Cash Flow | ||||||
| Free Cash Flow | 1.60B | 1.26B | 1.39B | 675.00M | 894.00M | 2.52B |
| Operating Cash Flow | 2.30B | 1.96B | 2.10B | 1.47B | 1.82B | 3.25B |
| Investing Cash Flow | -724.00M | -730.00M | -704.00M | -781.00M | -962.00M | -1.37B |
| Financing Cash Flow | -980.00M | -1.08B | -1.31B | -1.14B | -1.81B | -4.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $48.15B | 23.81 | 44.12% | 1.38% | 13.15% | 5.89% | |
71 Outperform | $23.84B | 22.02 | 53.29% | 1.37% | 1.30% | 1.14% | |
66 Neutral | $6.53B | 23.26 | -25.47% | ― | 1.78% | 75.71% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | $15.63B | 13.65 | 38.34% | 5.46% | 0.99% | 31.91% | |
56 Neutral | $8.24B | 37.48 | 51.43% | ― | 6.24% | -41.25% | |
54 Neutral | $9.99B | 13.08 | 8.00% | ― | 1.61% | 260.81% |